Jellagen Limited
Research and experimental development on biotechnology · Stirling
ActiveUnited KingdomIncorporated 2013Private Limited Company
Documents & history
Available account evidence and business events. This is not a complete filing history or document library.
Accounts to 2025-12-31
IXBRL · 130 source facts · 22 selected values
Validation findingsXBRL valid
Accounts to 2025-12-31
IXBRL · 130 source facts · 22 selected values
Validation findings
XBRL valid
- Reporting period
- 2025-01-01 to 2025-12-31
- Extraction status
- complete
- Numeric facts
- 86
- Documents processed
- 1
- XBRL standards validation
- valid
- Filing-profile validation
- invalid
- Parser
- arelle 2.44.4
- Taxonomy
- FRS-102-2025-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod223_4318_SC451036_20251231
- Source archive
- Accounts_Bulk_Data-2026-09-30.zip
Extraction findings: filing rules invalid. These describe source processing, not an audit opinion on the company.
Accounts to 2024-12-31
IXBRL · 129 source facts · 22 selected values
Validation findingsXBRL valid
Accounts to 2024-12-31
IXBRL · 129 source facts · 22 selected values
Validation findings
XBRL valid
- Reporting period
- 2024-01-01 to 2024-12-31
- Extraction status
- complete
- Numeric facts
- 85
- Documents processed
- 1
- XBRL standards validation
- valid
- Filing-profile validation
- invalid
- Parser
- arelle 2.44.4
- Taxonomy
- FRS-102-2023-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_2504_SC451036_20241231
- Source archive
- Accounts_Monthly_Data-April2025.zip
Extraction findings: filing rules invalid. These describe source processing, not an audit opinion on the company.
Accounts to 2023-12-31
IXBRL · 134 source facts · 22 selected values
Not assessedlegacy record
Accounts to 2023-12-31
IXBRL · 134 source facts · 22 selected values
Not assessed
legacy record
- Reporting period
- 2023-01-01 to 2023-12-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 89
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2023-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_2476_SC451036_20231231
- Source archive
- Accounts_Monthly_Data-September2024.zip
Accounts to 2022-12-31
IXBRL · 139 source facts · 22 selected values
Not assessedlegacy record
Accounts to 2022-12-31
IXBRL · 139 source facts · 22 selected values
Not assessed
legacy record
- Reporting period
- 2022-01-01 to 2022-12-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 82
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2023-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0022_SC451036_20221231
- Source archive
- Accounts_Monthly_Data-August2023.zip
Accounts to 2021-12-31
IXBRL · 130 source facts · 22 selected values
Not assessedlegacy record
Accounts to 2021-12-31
IXBRL · 130 source facts · 22 selected values
Not assessed
legacy record
- Reporting period
- 2021-01-01 to 2021-12-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 79
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2019-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0107_SC451036_20211231
- Source archive
- Accounts_Monthly_Data-June2022.zip
Accounts to 2020-12-31
IXBRL · 137 source facts · 22 selected values
Not assessedlegacy record
Accounts to 2020-12-31
IXBRL · 137 source facts · 22 selected values
Not assessed
legacy record
- Reporting period
- 2020-01-01 to 2020-12-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 84
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2019-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0093_SC451036_20201231
- Source archive
- Accounts_Monthly_Data-August2021.zip
Accounts to 2019-12-31
IXBRL · 139 source facts · 22 selected values
Not assessedlegacy record
Accounts to 2019-12-31
IXBRL · 139 source facts · 22 selected values
Not assessed
legacy record
- Reporting period
- 2019-01-01 to 2019-12-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 88
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2019-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0079_SC451036_20191231
- Source archive
- Accounts_Monthly_Data-June2020.zip
Accounts to 2018-12-31
IXBRL · 52 source facts · 12 selected values
Not assessedlegacy record
Accounts to 2018-12-31
IXBRL · 52 source facts · 12 selected values
Not assessed
legacy record
- Reporting period
- 2018-01-01 to 2018-12-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 18
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2014-09-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0069_SC451036_20181231
- Source archive
- Accounts_Monthly_Data-August2019.zip
Accounts to 2017-12-31
IXBRL · 48 source facts · 12 selected values
Not assessedlegacy record
Accounts to 2017-12-31
IXBRL · 48 source facts · 12 selected values
Not assessed
legacy record
- Reporting period
- 2017-01-01 to 2017-12-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 18
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2014-09-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0058_SC451036_20171231
- Source archive
- Accounts_Monthly_Data-September2018.zip
Accounts to 2016-12-31
IXBRL · 44 source facts · 12 selected values
Not assessedlegacy record
Accounts to 2016-12-31
IXBRL · 44 source facts · 12 selected values
Not assessed
legacy record
- Reporting period
- 2016-01-01 to 2016-12-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 18
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2014-09-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0046_SC451036_20161231
- Source archive
- Accounts_Monthly_Data-September2017.zip
Accounts to 2015-12-31
IXBRL · 98 source facts · 18 selected values
Not assessedlegacy record
Accounts to 2015-12-31
IXBRL · 98 source facts · 18 selected values
Not assessed
legacy record
- Reporting period
- 2015-01-01 to 2015-12-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 50
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- uk-gaap-full-2009-09-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0034_SC451036_20151231
- Source archive
- Accounts_Monthly_Data-September2016.zip
Accounts to 2014-12-31
IXBRL · 93 source facts · 18 selected values
Not assessedlegacy record
Accounts to 2014-12-31
IXBRL · 93 source facts · 18 selected values
Not assessed
legacy record
- Reporting period
- 2014-01-01 to 2014-12-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 48
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- uk-gaap-full-2009-09-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0021_SC451036_20141231
- Source archive
- Accounts_Monthly_Data-August2015.zip
Accounts to 2013-12-31
IXBRL · 0 source facts · 0 selected values
Not assessedlegacy record
Accounts to 2013-12-31
IXBRL · 0 source facts · 0 selected values
Not assessed
legacy record
- Reporting period
- — to —
- Extraction status
- Legacy / not assessed
- Numeric facts
- 0
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- Not recorded
- Currency
- Not recorded
- Source identifier
- Prod224_0010_SC451036_20131231
- Source archive
- Accounts_Monthly_Data-September2014.zip
Registered details
SC451036- Status
- Active
- Type
- Private Limited Company
- Incorporated
- 2013-05-29
- Jurisdiction
- —
- Registered office
- PAVILION 2, CASTLECRAIG BUSINESS PARK, STIRLING, FK7 7SH
Classification
1 SIC codes72110
Capital & company events
Reconstructed equity rounds and matched research funding.
Equity fundraising
2 SH01-derived rounds2022-10-21
£5,730,250 raised
£17,834,255 estimated post-money
2022-03-01
£1,519,015 raised
£10,571,195 estimated post-money
Research and innovation
9 matched grantsDevelopment of a collagen type 0 hydrogel for tendinopathy tissue healingLeadLive
Innovate UK · Collaborative R&D · 2024-06-01 – 2027-05-31
£273,190
awarded
The development of a novel inkjet bioprinter and software operating system, enabling high precision next generation 3D bioprinting.Innovate UK · Collaborative R&D · 2022-10-01 – 2024-04-30 · with 1 other participant£158,082awarded
The development of a novel inkjet bioprinter and software operating system, enabling high precision next generation 3D bioprinting.
Innovate UK · Collaborative R&D · 2022-10-01 – 2024-04-30 · with 1 other participant
£158,082
awarded
Jellagen Pty Ltd£158,082
Stroma Therapy against Covid-19 induced fibrosis (STACIF)Innovate UK · Collaborative R&D · 2021-01-01 – 2022-02-28 · with 2 other participants£19,800awarded
Stroma Therapy against Covid-19 induced fibrosis (STACIF)
Innovate UK · Collaborative R&D · 2021-01-01 – 2022-02-28 · with 2 other participants
£19,800
awarded
Development of a next generation collagen wound dressing containing a biofilm disruption agent.LeadInnovate UK · Collaborative R&D · 2019-03-01 – 2021-11-30 · with 2 other participants£323,821awarded
Development of a next generation collagen wound dressing containing a biofilm disruption agent.Lead
Innovate UK · Collaborative R&D · 2019-03-01 – 2021-11-30 · with 2 other participants
£323,821
awarded
Development of a next generation jellyfish collagen wound device targeting diabetic foot ulcerLead
Innovate UK · Collaborative R&D · 2017-08-01 – 2019-03-31
£329,088
awarded
Development of an active wound dressing built with electrospun jellyfish collagen and capable of delivering natural antimicrobial agentsInnovate UK · Feasibility Studies · 2016-03-01 – 2017-02-28 · with 2 other participants£23,172awarded
Development of an active wound dressing built with electrospun jellyfish collagen and capable of delivering natural antimicrobial agents
Innovate UK · Feasibility Studies · 2016-03-01 – 2017-02-28 · with 2 other participants
£23,172
awarded
A chemistry analysis conducted by Jellagen Pty Ltd into the functionalisation of collagen and its fabrication into novel wound healing devices targeting diabetic foot ulcers.Lead
Innovate UK · GRD Proof of Concept · 2015-06-01 – 2016-06-30
£97,477
awarded
Novel biomaterial extraction from existing marine waste water streamLead
Innovate UK · Vouchers · 2014-11-01 – 2015-04-30
£5,000
awarded
Process improvement to increase quality and yield, and new product prototyping by Jellagen Pty Ltd to explore new manufacturing processes utilising jellyfish derived medical grade Type I and Type II collagen.Lead
Innovate UK · GRD Proof of Concept · 2014-10-01 – 2015-09-30
£99,985
awarded